In conclusion, a novel tumor promotor PSMC2 was identified in ovarian cancer, which is upregulated in ovarian cancer, accelerating cell proliferation and colony formation, promoting cell migration, inhibiting cell apoptosis and predicting poor prognosis. This evidence concerns the gene PSMC2 and neoplasm.